China Shineway Pharmaceutical Group Limited (CSWYY) announced a profit for its full year that Increased, from last year
The company's bottom line totaled RMB949.95 million, or RMB1.26 per share. This compares with RMB840.05 million, or RMB1.11 per share, last year.
The company's revenue for the period fell 17.0% to RMB3.135 billion from RMB3.778 billion last year.
China Shineway Pharmaceutical Group Limited earnings at a glance (GAAP) :
-Earnings: RMB949.95 Mln. vs. RMB840.05 Mln. last year.-EPS: RMB1.26 vs. RMB1.11 last year.-Revenue: RMB3.135 Bln vs. RMB3.778 Bln last year.
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.